[支气管癌-辅助化疗]。

Langenbecks Archiv fur Chirurgie. Supplement II, Verhandlungen der Deutschen Gesellschaft fur Chirurgie. Deutsche Gesellschaft fur Chirurgie. Kongress Pub Date : 1990-01-01

P Drings

{"title":"[支气管癌-辅助化疗]。","authors":"P Drings","doi":"","DOIUrl":null,"url":null,"abstract":"Lung cancer patients with poor late prognosis should receive adjuvant chemotherapy. Its application in non-small cell lung cancer (NSCLC) is only justified in clinical studies, since there is no evidence of its efficacy. In small cell lung cancer (SCLC) chemotherapy is supplemented by local therapy regimens like radiotherapy and/or surgery. At present clinical studies are examining whether chemotherapy should be applied before or after surgical treatment.","PeriodicalId":77567,"journal":{"name":"Langenbecks Archiv fur Chirurgie. Supplement II, Verhandlungen der Deutschen Gesellschaft fur Chirurgie. Deutsche Gesellschaft fur Chirurgie. Kongress","volume":" ","pages":"89-94"},"PeriodicalIF":0.0000,"publicationDate":"1990-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Bronchial cancer--adjuvant chemotherapy].\",\"authors\":\"P Drings\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Lung cancer patients with poor late prognosis should receive adjuvant chemotherapy. Its application in non-small cell lung cancer (NSCLC) is only justified in clinical studies, since there is no evidence of its efficacy. In small cell lung cancer (SCLC) chemotherapy is supplemented by local therapy regimens like radiotherapy and/or surgery. At present clinical studies are examining whether chemotherapy should be applied before or after surgical treatment.\",\"PeriodicalId\":77567,\"journal\":{\"name\":\"Langenbecks Archiv fur Chirurgie. Supplement II, Verhandlungen der Deutschen Gesellschaft fur Chirurgie. Deutsche Gesellschaft fur Chirurgie. Kongress\",\"volume\":\" \",\"pages\":\"89-94\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1990-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Langenbecks Archiv fur Chirurgie. Supplement II, Verhandlungen der Deutschen Gesellschaft fur Chirurgie. Deutsche Gesellschaft fur Chirurgie. Kongress\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Langenbecks Archiv fur Chirurgie. Supplement II, Verhandlungen der Deutschen Gesellschaft fur Chirurgie. Deutsche Gesellschaft fur Chirurgie. Kongress","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

晚期预后差的肺癌患者应接受辅助化疗。其在非小细胞肺癌(NSCLC)中的应用仅在临床研究中得到证实，因为没有证据表明其疗效。在小细胞肺癌(SCLC)中，化疗辅以局部治疗方案，如放疗和/或手术。目前的临床研究正在探讨化疗是否应该在手术治疗之前或之后应用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

[Bronchial cancer--adjuvant chemotherapy].

Lung cancer patients with poor late prognosis should receive adjuvant chemotherapy. Its application in non-small cell lung cancer (NSCLC) is only justified in clinical studies, since there is no evidence of its efficacy. In small cell lung cancer (SCLC) chemotherapy is supplemented by local therapy regimens like radiotherapy and/or surgery. At present clinical studies are examining whether chemotherapy should be applied before or after surgical treatment.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Langenbecks Archiv fur Chirurgie. Supplement II, Verhandlungen der Deutschen Gesellschaft fur Chirurgie. Deutsche Gesellschaft fur Chirurgie. Kongress

自引率

0.00%

发文量